Failure of health-care bill barely causes a ripple.
Answering questions from the Biotech Mailbag on FLXN and SGYP.
The health care debate isn't about health care. It is about leadership and deal making.
If it passes, interest rates and stocks should go higher.
At stake is whether the Republicans can work out their differences.
The Obamacare vote will be the catalyst for a move today, but whether there is a V-shaped recovery or a failed bounce is the question.
We're due for a bounce, but the narrative may not follow the script.
Vote on Obamacare repeal may serve as catalyst.
A little patience is required, but sooner or later some solid support should develop.
After another technical look at GSK, this FTSE component is still going strong.

Columnist Conversations

SPX weekly View Chart »  View in New Window » $SPX Daily


News Breaks

Powered by


Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.